Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pumps Achieve High-Speed Sorting of Large Cells

By LabMedica International staff writers
Posted on 10 Aug 2017
The sorting of individual cells is necessary for many medical applications, including the isolation of specific cell types from cell suspensions. More...
A fluorescence-activated cell sorting (FACS) has been used for high-throughput cell sorting.

A FACS of larger cells requires the samples to be processed under low pressure through wider nozzles to prevent damage and therefor sorting is limited to low-level throughput. Lasers are used to excite auto-fluorescence or tagged-fluorescence of cell included in droplets, and then the droplets are diverted into different containers depending on their characteristics. This technique is a concern owing to sample infections due to aerosols generation.

Scientists at Nagoya University (Nagoya, Japan) investigating cell sorting used a microfluidic chip to prevent sample infection. This chip has microchannels into which cell suspensions are introduced for sorting. The group integrated two externally driven on-chip pumps into the microfluidic chip for high-speed flow control. Using a high-speed actuator as the driving source of pump, they succeeded in producing a flow with 16 microseconds for cell sorting.

Although various methods of on-chip cell sorting have been proposed, high-throughput sorting of large cells remains hampered by the difficulty of controlling high-speed flow over a wide sorting area. To overcome this problem, the team proposed high-speed local-flow control using dual membrane pumps driven by piezoelectric actuators placed on the outside of a microfluidic chip. They evaluated the controllability of shifting the flow profile by the local-flow.

The technique allows them to sort not only large but also small cells with high speed, high purity, and high viability. The method was tested on microalgae as an example of large cells, around 100 µM in size, and achieved 95.8% purity, 90.8% viability, and a 92.8% success rate. As a model small cell type, they used a cancer cell whose size is around 24 µM, and achieved 98.9% purity, 90.7% viability, and a 97.8% success rate.

Shinya Sakuma, PhD, an assistant professor and lead author said, “Microfluidic chip contains a cross-shaped sorting area and three-branched microfluidic channel. Target/non-target cells are three-dimensionally aligned in the main channel. When target cells are detected, the on-chip pumps work rapidly to sort cells into one of two interest channels. Meanwhile, non-target cells are flushed into the waste channel without pump actuation.” The study was first published on June 14, 2017, in the journal Lab Chip.

Related Links:
Nagoya University


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.